News | March 19, 2014

ICPME Offers Molecular Breast Imaging CME Course

Nuclear Imaging Mammogrpahy Women's Health ICPME MBI Molecular Breast Imaging

March 19, 2014 — Molecular breast imaging (MBI) Clinical Indications, Benefits and Challenges is the focus of a new CME credit course to be offered by ICPME. It is funded in part by Gamma Medica Inc. and in part by GE Healthcare. The one-hour online session will provide a thorough overview of MBI, which is a growing imaging technology for women with dense breasts and certain difficult-to-image cancers.

Research has shown that for women with dense breasts, MBI technology outperformed mammography in finding more cancers. This makes MBI, which has the ability to detect breast cancer lesions as small as 5 mm, a highly effective secondary diagnostic tool. This is particularly true for women with dense breast tissue and who have inconclusive results on their initial mammograms.

MBI’s ability to detect smaller lesions lies in its ability to use molecular functional imaging, allowing for breast abnormalities to be detected based on altered characteristics of the tissue. Functional imaging is important for distinguishing between a viable and nonviable mass because functional changes precede anatomical changes in breast tissue.

The certified pre-recorded session is presented by Stephen W. Phillips, M.D., FACR, medical director of Methodist Sugar Land Hospital Breast Center (MSLH), assistant professor of radiology at Weill Cornell Medical College, New York, and formerly assistant professor of radiology at Mayo Clinic. Since 2012, Phillips has played a role in MBI clinical research at MSLH, where he currently utilizes MBI as a contributor to the general health and well-being of women in the greater Texas area.

The course assesses the role of MBI as a complementary tool to mammography, describes patient indications for use, evaluates MBI benefits and challenges and covers the counseling of patients with dense breast tissue. It is accredited for 1.0 AMA PRA Category 1 credit and participants can register on the ICPME.

For more information:

Related Content

Comparison of Screening Recommendations Supports Annual Mammography
News | Mammography | August 22, 2017
When to initiate screening for breast cancer, how often to screen, and how long to screen are questions that continue...
ASNC and SNMMI Release Joint Document on Diagnosis, Treatment of Cardiac Sarcoidosis
News | Cardiac Imaging | August 18, 2017
August 18, 2017 — The American Society of Nuclear Cardiology (ASNC) has released a joint expert consensus document wi
Houston Methodist Hospital Enters Multi-Year Technology and Research Agreement With Siemens Healthineers
News | Imaging | August 17, 2017
Houston Methodist Hospital and Siemens Healthineers have entered into a multi-year agreement to bring cutting-edge...
Study Demonstrates First Human Application of Novel PET Tracer for Prostate Cancer

Transaxial 11Csarcosine hybrid PET/CT showed a (triangulated) adenocarcinoma in the transition zone of the anterior right prostate gland on PET (A), CT (B), and a separately obtained T2?weighted MR sequence (C) with resulting PET/MRI registration (D). Image courtesy of M. Piert et al., University of Michigan, Ann Arbor, Mich.

News | Radiopharmaceuticals and Tracers | August 16, 2017
In the featured translational article in the August issue of The Journal of Nuclear Medicine, researchers at the...
Clinical Data Supports Use of Xoft System for Endometrial Cancer
News | Brachytherapy Systems | August 03, 2017
Researchers presented clinical data supporting use of the Xoft Axxent Electronic Brachytherapy (eBx) System for the...
The ASPIRE Cristalle FFDM system with DBT combines Fujifilm’s state-of-the-art hexagonal close pattern (HCP) detector design, advanced image processing and image acquisition workflow
News | Women's Health | August 01, 2017
Fujifilm Medical Systems U.S.A., Inc. announced that The Mammography Center of Monterey, an ACR-accredited breast...
Sponsored Content | Videos | Breast Imaging | July 28, 2017
Nancy Cappello, Ph.D., executive director and founder of Are You Dense Inc. and Are You Dense Advocacy, explains how
Radiotherapy Prior to Surgery Reduces Secondary Tumor Risk in Early-Stage Breast Cancer Patients
News | Radiation Therapy | July 24, 2017
Moffitt Cancer Center researchers launched a first-of-its-kind study comparing the long-term benefits of radiation...
Overlay Init